Insiders · APVO

APVO insider transactions

Aptevo Therapeutics Inc. (APVO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for APVO

• 14d
  New insider Janatpour Mary Jo claimed no ownership of stock in the company (SEC Form 3)

  3 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 211d
  Director Grant Grady Iii bought $20,134 worth of shares (13,513 units at $1.49), increasing direct ownership by 1,351,300% to 13,514 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 251d
  SEC Form 4 filed by Large owner Bank Of America Corp /De/

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 251d
  New insider Bank Of America Corp /De/ claimed ownership of 27 shares (SEC Form 3)

  3 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by Director Abdun-Nabi Daniel

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by SVP, CFO Taylor Daphne

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by Director Grant Grady Iii

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by SVP, CMO Huebner Dirk

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by Director Niederhuber John

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by EVP, COO Lamothe Jeffrey G.

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by President and CEO White Marvin L

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by Director Kunz Barbara Lopez

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by SVP, GC, BD & Corp Affairs Kwon Soyoung

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 307d
  SEC Form 4 filed by Director Harsanyi Zsolt

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  Director Harsanyi Zsolt converted options into 1 shares (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  Director Kunz Barbara Lopez converted options into 1 shares (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  Director Abdun-Nabi Daniel converted options into 1 shares (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  Director Grant Grady Iii converted options into 1 shares (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  Director Niederhuber John converted options into 1 shares (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  SVP, CFO Taylor Daphne converted options into 3 shares (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  SVP, GC, BD & Corp Affairs Kwon Soyoung converted options into 3 shares, increasing direct ownership by 300% to 4 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  President and CEO White Marvin L converted options into 10 shares, increasing direct ownership by 500% to 12 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 325d
  EVP, COO Lamothe Jeffrey G. converted options into 5 shares, increasing direct ownership by 500% to 6 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 337d
  New insider Huebner Dirk claimed no ownership of stock in the company (SEC Form 3)

  3 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 464d
  SVP, GC, BD & Corp Affairs Kwon Soyoung converted options into 4 shares, increasing direct ownership by 19% to 25 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 464d
  EVP, COO Lamothe Jeffrey G. converted options into 5 shares, increasing direct ownership by 16% to 36 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 464d
  President and CEO White Marvin L converted options into 14 shares, increasing direct ownership by 34% to 55 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 464d
  SVP, CFO Taylor Daphne converted options into 3 shares, increasing direct ownership by 20% to 18 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 671d
  SVP, GC, BD & Corp Affairs Kwon Soyoung converted options into 213 shares, increasing direct ownership by 36% to 801 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 671d
  EVP, COO Lamothe Jeffrey G. converted options into 314 shares, increasing direct ownership by 37% to 1,166 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 671d
  SVP, CFO Taylor Daphne converted options into 158 shares, increasing direct ownership by 38% to 576 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by Director Harsanyi Zsolt

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by SVP, CFO Taylor Daphne

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by Director Grant Grady Iii

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by SVP, GC, BD & Corp Affairs Kwon Soyoung

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by EVP, COO Lamothe Jeffrey G.

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by President and CEO White Marvin L

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by Director Niederhuber John

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by Director Kunz Barbara Lopez

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 692d
  SEC Form 4 filed by Director Abdun-Nabi Daniel

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 738d
  Niederhuber John converted options into 88 shares, increasing direct ownership by 68% to 217 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 738d
  Abdun-Nabi Daniel converted options into 88 shares, increasing direct ownership by 47% to 277 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 738d
  Harsanyi Zsolt converted options into 88 shares, increasing direct ownership by 46% to 280 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 738d
  Kunz Barbara Lopez converted options into 88 shares, increasing direct ownership by 80% to 198 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 738d
  Grant Grady Iii converted options into 88 shares, increasing direct ownership by 80% to 198 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 738d
  Kwon Soyoung converted options into 42 shares, increasing direct ownership by 8% to 588 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 828d
  Taylor Daphne converted options into 5,251 shares, increasing direct ownership by 40% to 18,411 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 828d
  Lamothe Jeffrey G. converted options into 9,167 shares, increasing direct ownership by 32% to 37,504 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 828d
  White Marvin L converted options into 22,501 shares, increasing direct ownership by 50% to 67,430 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 828d
  Kwon Soyoung converted options into 7,334 shares, increasing direct ownership by 44% to 24,042 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 863d
  Taylor Daphne converted options into 792 shares, increasing direct ownership by 6% to 13,160 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 863d
  Lamothe Jeffrey G. converted options into 1,833 shares, increasing direct ownership by 7% to 28,337 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 863d
  White Marvin L converted options into 4,792 shares, increasing direct ownership by 12% to 44,929 units (SEC Form 4)

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Niederhuber John converted options into 3,571 shares, increasing direct ownership by 169% to 5,682 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Kunz Barbara Lopez converted options into 3,571 shares, increasing direct ownership by 273% to 4,880 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Harsanyi Zsolt converted options into 3,571 shares, increasing direct ownership by 73% to 8,475 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Grant Grady Iii converted options into 3,571 shares, increasing direct ownership by 273% to 4,880 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Abdun-Nabi Daniel converted options into 3,571 shares, increasing direct ownership by 75% to 8,339 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Taylor Daphne converted options into 6,945 shares, increasing direct ownership by 128% to 12,368 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)
• 1036d
  SEC Form 4: Kwon Soyoung converted options into 9,375 shares, increasing direct ownership by 128% to 16,708 units

  4 - Aptevo Therapeutics Inc. (0001671584) (Issuer)